UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036094
Receipt number R000041118
Scientific Title The effect of Multidisciplinary Perioperative REhabilitative Program for esophageal cancer patients undergoing neoadjuvant chemotherapy (M-PREP): Phase I and II study
Date of disclosure of the study information 2019/03/13
Last modified on 2021/03/09 16:58:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of Multidisciplinary Perioperative REhabilitative Program for esophageal cancer patients undergoing neoadjuvant chemotherapy (M-PREP): Phase I and II study

Acronym

The effect of Multidisciplinary Perioperative REhabilitative Program for esophageal cancer patients undergoing neoadjuvant chemotherapy (M-PREP): Phase I and II study

Scientific Title

The effect of Multidisciplinary Perioperative REhabilitative Program for esophageal cancer patients undergoing neoadjuvant chemotherapy (M-PREP): Phase I and II study

Scientific Title:Acronym

The effect of Multidisciplinary Perioperative REhabilitative Program for esophageal cancer patients undergoing neoadjuvant chemotherapy (M-PREP): Phase I and II study

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to clarify the effect of multidisciplinary perioperative rehabilitative program for esophageal cancer patients undergoing neoadjuvant chemotherapy.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

adherence

Key secondary outcomes

postoperative complications,safety(any compliations associated with rehabilitation).6 minute walk test, hand grip, lower limb strength, pulmonary function, respiratory muscle strength, swallowing function, quality of life, albumin,and prealbumin are measured before chemotherapy, before surgery, and three months after surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Patients undergoing neoadjucvant chemotherapy for advanced esophageal cancer
(2)Patients can understand the rehabilitation program and participate with a will of their own.
(3)Informed consent for this study is obtained.

Key exclusion criteria

(1)patients with epilepsy, stroke with palsy, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis or severe heart disease
(2)patients with a high risk for falling down
(3)patients who cannot perform self training safely
(4)patients who are judged by doctors innapropriate to participate in this study


Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yasuyuki
Middle name
Last name Seto

Organization

Graduate School of Medicine, The university of Tokyo

Division name

Department of gastrointestinal Surgery

Zip code

113-8655

Address

7-3-1, Hongou, Bunkyo-ku, Tokyo

TEL

+81-3-3815-5411

Email

seto-tky@umin.ac.jp


Public contact

Name of contact person

1st name Yasuyuki
Middle name
Last name Seto

Organization

Graduate School of Medicine, The university of Tokyo

Division name

Department of gastrointestinal Surgery

Zip code

113-8655

Address

7-3-1, Hongou, Bunkyo-ku, Tokyo

TEL

+81-3-3815-5411

Homepage URL


Email

raito.asaoka@icloud.com


Sponsor or person

Institute

Department of gastrointestinal Surgery, Graduate School of Medicine, The university of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Department of gastrointestinal Surgery, Graduate School of Medicine, The university of Tokyo

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Office for Human Research StudiesGraduate School of Medicine and Faculty of Medicine The University of Tokyo

Address

7-3-1 Hongou

Tel

+81338155411

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 05 Day

Date of IRB

2019 Year 02 Month 21 Day

Anticipated trial start date

2019 Year 03 Month 15 Day

Last follow-up date

2021 Year 02 Month 28 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete

2021 Year 03 Month 31 Day

Date analysis concluded

2021 Year 04 Month 30 Day


Other

Other related information

We aim this study to claryfy the effect of multidisciplinary perioperative rehabilitative program for esophageal cancer patients undergoing neoadjuvant chemotherapy.


Management information

Registered date

2019 Year 03 Month 05 Day

Last modified on

2021 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041118


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name